Pharmacopoeial Quality Requirements for Compounded Pharmaceuticals: Present and Future
- Autores: Shishova L.I.1, Sakanyan E.I.1, Shemeryankina T.B.1, Gubareva O.N.1
-
Afiliações:
- Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- Edição: Volume 51, Nº 8 (2017)
- Páginas: 731-734
- Seção: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244778
- DOI: https://doi.org/10.1007/s11094-017-1683-3
- ID: 244778
Citar
Resumo
Issues related to regulation of the quality of compounded medicinal preparations by the State Pharmacopoeia of the Russian Federation are considered. Topical questions of the development and implementation of both general clauses and particular monographs related to compounded pharmaceuticals in national pharmacopoeial science and practice are discussed.
Sobre autores
L. Shishova
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051
E. Sakanyan
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051
T. Shemeryankina
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051
O. Gubareva
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051
Arquivos suplementares
